Skip to main content

Table 4 Mean and (SD) of the spatiotemporal gait parameters for the non-respondent and respondent groups at Pre 1, Pre 2 and Post 1

From: Fampridine and quality of life in individuals with multiple sclerosis

Spatiotemporal gait parameters Non-respondent (n = 35) Respondent (n = 15)
Pre 1 Pre 2 Post 1 Pre 1 Pre 2 Post 1
Velocity (m s−1) 1.21 (0.44) 1.2 (0.48) 1.27 (0.46) 0.66 (0.36) 0.78 (0.48)* 1.03 (0.51) £
Cadence (steps min−1) 115.11 (23.03) 113.29 (25.98) 116.35 (23.83) 82.03 (27.97) 90.89 (30.4)** 104.48 (26.18) £
Step length (m) 0.62 (0.15) 0.62 (0.16) 0.64 (0.16) 0.46 (0.15) 0.49 (0.18)** 0.57 (0.16) £
Step time (s) 0.55 (0.14) 0.57 (0.17) 0.54 (0.14) 0.83 (0.32) 0.75 (0.28) 0.62 (0.18)***
Step width (m) 0.13 (0.05) 0.13 (0.04) 0.12 (0.04) 0.14 (0.07) 0.14 (0.07) 0.12 (0.06)
Stance time (% GC) 64.32 (4.17) 64.58 (4.83) 63.55 (4.6) 70.01 (5.94) 68.76 (6.34) 65.46 (4.12)***
Double supp. time (% GC) 29.1 (8.22) 29.4 (9.66) 28.12 (8.12) 40.53 (12.23) 37.76 (12.86) 31.25 (8.34)***
  1. The italic values correspond statistical significant differences
  2.  p < 0.05 Pre 1 versus Post 1
  3. p < 0.05 Pre 1 versus Pre 2
  4. ** p < 0.01 Pre 1 versus Pre 2
  5. *** p 10−3 Pre 1 and Pre 2 versus Post 1
  6. £ p 10−4 Pre 1 and Pre 2 versus Post 1